Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

Landier W, Hageman L, Chen Y, Kornegay N, Evans WE, Bostrom BC, Casillas J, Dickens DS, Angiolillo AL, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S.

J Clin Oncol. 2017 May 20;35(15):1730-1736. doi: 10.1200/JCO.2016.71.7579. Epub 2017 Mar 24.

PMID:
28339328
2.

Utility of peripheral blood immunophenotyping by flow cytometry in the diagnosis of pediatric acute leukemia.

Metrock LK, Summers RJ, Park S, Gillespie S, Castellino S, Lew G, Keller FG.

Pediatr Blood Cancer. 2017 Mar 23. doi: 10.1002/pbc.26526. [Epub ahead of print]

PMID:
28333411
3.

Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.

Zerra P, Bergsagel J, Keller FG, Lew G, Pauly M.

Pediatr Blood Cancer. 2016 Apr;63(4):712-5. doi: 10.1002/pbc.25841. Epub 2015 Nov 24.

PMID:
26878433
4.

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.

Bhatia S, Landier W, Hageman L, Chen Y, Kim H, Sun CL, Kornegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Wong FL, Relling MV.

JAMA Oncol. 2015 Jun;1(3):287-95. doi: 10.1001/jamaoncol.2015.0245.

5.

Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.

Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE.

JAMA. 2015 Feb 24;313(8):815-23. doi: 10.1001/jama.2015.0894.

6.

“Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia.

Bunting ST, Lew G.

Blood. 2014 Apr 17;123(16):2448. doi: 10.1182/blood-2014-01-547513. No abstract available.

7.

Comparison of allergic reactions to intravenous and intramuscular pegaspargase in children with acute lymphoblastic leukemia.

Petersen WC Jr, Clark D, Senn SL, Cash WT, Gillespie SE, McCracken CE, Keller FG, Lew G.

Pediatr Hematol Oncol. 2014 May;31(4):311-7. doi: 10.3109/08880018.2013.876134. Epub 2014 Feb 5.

PMID:
24498943
8.

Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.

Nickel RS, Keller F, Bergsagel J, Cooper T, Daves M, Sabnis H, Lew G.

Pediatr Blood Cancer. 2014 May;61(5):810-4. doi: 10.1002/pbc.24892. Epub 2013 Dec 19.

9.

Parent participation and physician-parent communication during informed consent in child leukemia.

Cousino M, Hazen R, Yamokoski A, Miller V, Zyzanski S, Drotar D, Kodish E; Multi-site Intervention Study to Improve Consent Research Team.

Pediatrics. 2011 Dec;128(6):e1544-51. doi: 10.1542/peds.2010-3542. Epub 2011 Nov 7.

10.

Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.

Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I.

Clin Cancer Res. 2010 Mar 15;16(6):1894-903. doi: 10.1158/1078-0432.CCR-09-2980. Epub 2010 Mar 9.

11.

A feasibility trial of a video intervention to improve informed consent for parents of children with leukemia.

Hazen RA, Eder M, Drotar D, Zyzanski S, Reynolds AE, Reynolds CP, Kodish E, Noll RB; Multi-Site Intervention Study to Improve Consent Research Team.

Pediatr Blood Cancer. 2010 Jul 15;55(1):113-8. doi: 10.1002/pbc.22411.

12.

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia.

Herrera L, Bostrom B, Gore L, Sandler E, Lew G, Schlegel PG, Aquino V, Ghetie V, Vitetta ES, Schindler J.

J Pediatr Hematol Oncol. 2009 Dec;31(12):936-41. doi: 10.1097/MPH.0b013e3181bdf211.

PMID:
19875969
13.

AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer.

Yang S, Ngo VC, Lew GB, Chong LW, Lee SS, Ong WJ, Lam WL, Thng CH, Koong HN, Ong HS, Chung A, Chow P, Lee J, Soo KC, Huynh H.

Mol Cancer Ther. 2009 Sep;8(9):2537-45. doi: 10.1158/1535-7163.MCT-09-0213. Epub 2009 Sep 1.

14.

A physician-directed intervention: teaching and measuring better informed consent.

Yap TY, Yamokoski A, Noll R, Drotar D, Zyzanski S, Kodish ED; Multi-site Intervention Study to Improve Consent Research Team.

Acad Med. 2009 Aug;84(8):1036-42. doi: 10.1097/ACM.0b013e3181acfbcd.

PMID:
19638769
15.

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.

Huynh H, Lee JW, Chow PK, Ngo VC, Lew GB, Lam IW, Ong HS, Chung A, Soo KC.

Mol Cancer Ther. 2009 Jan;8(1):152-9. doi: 10.1158/1535-7163.MCT-08-0553.

16.

Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.

Crosswell HE, Bergsagel DJ, Yost R, Lew G.

Pediatr Blood Cancer. 2008 Apr;50(4):883-5.

PMID:
17278123
17.

Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.

Howell DL, Lew G, Comeaux LG, Meacham LR.

Pediatr Blood Cancer. 2007 Sep;49(3):349-52.

PMID:
16602119
18.

Is the cystatin-like domain of TSL functionally active in external ocular infections and during the normal diurnal cycle?

Sack RA, Sathe S, Beaton A, Kozinski M, Bogart B, Lew G, Sharma S, Upponi A.

Exp Eye Res. 2004 Mar;78(3):371-8.

PMID:
15106915
20.

Supplemental Content

Loading ...
Support Center